These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

750 related items for PubMed ID: 28951106

  • 1. In vitro interaction of ceftazidime-avibactam in combination with different antimicrobials against KPC-producing Klebsiella pneumoniae clinical isolates.
    Gaibani P, Lewis RE, Volpe SL, Giannella M, Campoli C, Landini MP, Viale P, Re MC, Ambretti S.
    Int J Infect Dis; 2017 Dec; 65():1-3. PubMed ID: 28951106
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Generating Genotype-Specific Aminoglycoside Combinations with Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae.
    Huang Y, Sokolowski K, Rana A, Singh N, Wang J, Chen K, Lang Y, Zhou J, Kadiyala N, Krapp F, Ozer EA, Hauser AR, Li J, Bulitta JB, Bulman ZP.
    Antimicrob Agents Chemother; 2021 Aug 17; 65(9):e0069221. PubMed ID: 34152820
    [Abstract] [Full Text] [Related]

  • 5. Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates.
    Giddins MJ, Macesic N, Annavajhala MK, Stump S, Khan S, McConville TH, Mehta M, Gomez-Simmonds A, Uhlemann AC.
    Antimicrob Agents Chemother; 2018 Mar 17; 62(3):. PubMed ID: 29263067
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates.
    Maraki S, Mavromanolaki VE, Magkafouraki E, Moraitis P, Stafylaki D, Kasimati A, Scoulica E.
    Infection; 2022 Apr 17; 50(2):467-474. PubMed ID: 34854060
    [Abstract] [Full Text] [Related]

  • 8. Activity of Ceftazidime-Avibactam Alone and in Combination with Ertapenem, Fosfomycin, and Tigecycline Against Carbapenemase-Producing Klebsiella pneumoniae.
    Ojdana D, Gutowska A, Sacha P, Majewski P, Wieczorek P, Tryniszewska E.
    Microb Drug Resist; 2019 Nov 17; 25(9):1357-1364. PubMed ID: 31295055
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In Vitro Activity of Ceftazidime/Avibactam Alone and in Combination With Fosfomycin and Carbapenems Against KPC-producing Klebsiella Pneumoniae.
    Romanelli F, De Robertis A, Carone G, Dalfino L, Stufano M, Del Prete R, Mosca A.
    New Microbiol; 2020 Jul 17; 43(3):136-138. PubMed ID: 32596740
    [Abstract] [Full Text] [Related]

  • 14. Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance.
    López-Hernández I, Alonso N, Fernández-Martínez M, Zamorano L, Rivera A, Oliver A, Conejo MC, Martínez-Martínez L, Navarro F, Pascual A.
    Enferm Infecc Microbiol Clin; 2017 Oct 17; 35(8):499-504. PubMed ID: 27887765
    [Abstract] [Full Text] [Related]

  • 15. In Vitro Mechanisms of Resistance Development to Imipenem-Relebactam in KPC-Producing Klebsiella pneumoniae.
    Findlay J, Rens C, Poirel L, Nordmann P.
    Antimicrob Agents Chemother; 2022 Oct 18; 66(10):e0091822. PubMed ID: 36154170
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z, Kayacan C, Oncul O.
    Int J Antimicrob Agents; 2012 Jan 18; 39(1):86-9. PubMed ID: 22041508
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.
    Galani I, Souli M, Nafplioti K, Adamou P, Karaiskos I, Giamarellou H, Antoniadou A, Study Collaborators.
    Eur J Clin Microbiol Infect Dis; 2019 Jun 18; 38(6):1143-1150. PubMed ID: 30825054
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.